Protein geranylgeranyltransferase-I (GGTase-I) catalyzes the transfer of a 20-carbon isoprenoid lipid to the sulfur of a cysteine residue located near the C terminus of numerous cellular proteins, including members of the Rho superfamily of small GTPases and other essential signal transduction proteins. In humans, GGTase-I and the homologous protein farnesyltransferase (FTase) are targets of anticancer therapeutics because of the role small GTPases play in oncogenesis. Protein prenyltransferases are also essential for many fungal and protozoan pathogens that infect humans, and have therefore become important targets for treating infectious diseases. Candida albicans, a causative agent of systemic fungal infections in immunocompromised individuals, is one pathogen for which protein prenylation is essential for survival. Here we present the crystal structure of GGTase-I from C. albicans (CaGGTase-I) in complex with its cognate lipid substrate, geranylgeranylpyrophosphate. This structure provides a high-resolution picture of a non-mammalian protein prenyltransferase. There are significant variations between species in critical areas of the active site, including the isoprenoid-binding pocket, as well as the putative product exit groove. These differences indicate the regions where specific protein prenyltransferase inhibitors with antifungal activity can be designed.Candida albicans is an opportunistic pathogen associated with a variety of diseases, ranging from common vaginal yeast infections and oral thrush, to systemic fungal infections in immunocompromised individuals, such as AIDS patients and transplant recipients (1, 2). Estimates place the morbidity rate for systemic C. albicans infections that have reached the bloodstream at between 20 and 47% (1, 2). In addition, emerging resistance of C. albicans to existing antifungal therapies such as fluconazole has prompted a search for new drugs (3).The protein prenylation pathway may be a potential new target for antifungal treatment (4 -8). Prenylation is an essential post-translational lipid modification for more than 120 cellular proteins, including the signal transduction proteins in the Ras, Rho, and Rab families, PRL-family tyrosine phosphatases, centromeric proteins, and nuclear lamins (9, 10). Most eukaryotes possess three protein prenyltransferases: protein farnesyltransferase (FTase) adds a 15-carbon isoprenoid lipid. Protein geranylgeranyltransferase-I (GGTase-I) 2 a single 20-carbon isoprenoid lipid, and protein geranylgeranyltransferase-II (GGTase-II or Rab GGTase) successively adds two 20-carbon isoprenoid lipids. In each case, the lipid is transferred to the ␥ sulfur of the cysteine residue. All three protein prenyltransferases are obligate heterodimers and share a homologous architecture. Both FTase and GGTase-I prenylate a C-terminal CaaX tetrapeptide recognition sequence of their substrate proteins (C, cysteine; aa, two generally aliphatic residues; and X, a specificity determining residue). The X-residue usually determines the cognate substrate f...